MacKay; Fabienne

Patent Applications and Registrations

Patent applications and USPTO patent grants for MacKay; Fabienne.The latest application filed is for "methods of modulating immune responses using bcma polypeptide".

Company Profile

2.10.17

MacKay; Fabienne - Vaucluse AU
Mackay; Fabienne - Watertown MA
Mackay; Fabienne - New South Wales AU

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Modulating Immune Responses Using Bcma Polypeptide App 20200095305 - Browning; Jeffrey ; et al.	2020-03-26
Methods of modulating immune responses using BCMA polypeptide Grant 10,494,416 - Browning , et al. De	2019-12-03
Methods Of Modulating Immune Responses Using Bcma Polypeptide App 20180273605 - Browning; Jeffrey ; et al.	2018-09-27
Methods of treating autoimmune diseases using a B-cell maturation antigen (BCMA) Grant 9,650,430 - Browning , et al. May 16, 2	2017-05-16
Baff Receptor (bcma), An Immunoregulatory Agent App 20150139992 - Browning; Jeffrey ; et al.	2015-05-21
Methods of screening for a compound that inhibits the interaction between BAFF and BCMA Grant 8,828,669 - Browning , et al. September 9, 2	2014-09-09
Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases Grant 8,287,874 - Browning , et al. October 16, 2	2012-10-16
Soluble Lymphotoxin-beta Receptors And Anti-lymphotoxin Receptor And Ligand Antibodies As Therapeutic Agents For The Treatment Of Immunological Diseases App 20120156214 - BROWNING; Jeffrey L. ; et al.	2012-06-21
BAFF, inhibitors thereof and their use in the modulation of B-cell response App 20100233179 - Browning; Jeffrey ; et al.	2010-09-16
Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases Grant 7,744,891 - Browning , et al. June 29, 2	2010-06-29
BAFF, Inhibitors Thereof and Their Use in the Modulation of B-Cell Response and Treatment of Autoimmune Disorders App 20090110676 - MACKAY; FABIENNE ; et al.	2009-04-30
Use of Baff to Treat Th2-Mediated Conditions App 20080254030 - Mackay; Charles ; et al.	2008-10-16
Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases App 20080219967 - Browning; Jeffrey L. ; et al.	2008-09-11
Soluble lymphotoxin-.beta. receptors as therapeutic agents for the treatment of systemic lupus erythematosus Grant 7,309,492 - Browning , et al. December 18, 2	2007-12-18
Use of lymphotoxin-.beta. receptor blocking agents for the treatment of antibody mediated immunological diseases Grant 7,255,854 - Browning , et al. August 14, 2	2007-08-14
Methods of treatment by administering an anti-BCMA antibody Grant 7,083,785 - Browning , et al. August 1, 2	2006-08-01
BAFF, inhibitors thereof and their use in the modulation of B-cell response App 20060079457 - Browning; Jeffrey ; et al.	2006-04-13
BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders App 20050244411 - MacKay, Fabienne ; et al.	2005-11-03
BAFF, inhibitors thereof and their use in the modulation of B-cell response App 20050169924 - Browning, Jeffrey ; et al.	2005-08-04
BAFF, inhibitors thereof and their use in the modulation of B-cell response App 20050100548 - Browning, Jeffrey ; et al.	2005-05-12
BAFF, inhibitors thereof and their use in the modulation of B-cell response Grant 6,869,605 - Browning , et al. March 22, 2	2005-03-22
BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders App 20030095967 - MacKay, Fabienne ; et al.	2003-05-22
Soluble lymphotoxin beta receptor and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for treatment App 20020197254 - Browning, Jeffrey L. ; et al.	2002-12-26
BAFF receptor (BCMA), an immunoregulatory agent App 20020165156 - Browning, Jeffrey ; et al.	2002-11-07
BAFF, inhibitors thereof and their use in the modulation of B-cell response App 20020037852 - Browning, Jeffrey ; et al.	2002-03-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.